Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]
News [3588]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
Nano-radiomics unveils treatment effect on tumour microenvironment
Nano-radiomics unveils treatment effect on tumour microenvironment
Mapping the immune landscape of haematological cancers may help to enhance therapies
Mapping the immune landscape of haematological cancers may help to enhance therapies
Drug treatment could improve effectiveness of immunotherapy for cancer patients
Drug treatment could improve effectiveness of immunotherapy for cancer patients
A helping hand for cancer immunotherapy
A helping hand for cancer immunotherapy
A key gene modifies regulatory T cells to fine-tune the immune response
A key gene modifies regulatory T cells to fine-tune the immune response
Engineered killer immune cells target tumours and their immunosuppressive allies
Engineered killer immune cells target tumours and their immunosuppressive allies
FDA approves avelumab for urothelial carcinoma maintenance treatment
FDA approves avelumab for urothelial carcinoma maintenance treatment
FDA approves first-line immunotherapy for patients with MSI-H/dMMR metastatic colorectal cancer
FDA approves first-line immunotherapy for patients with MSI-H/dMMR metastatic colorectal cancer
FDA approves combination of pertuzumab, trastuzumab, and hyaluronidase-zzxf for HER2-positive breast cancer
FDA approves combination of pertuzumab, trastuzumab, and hyaluronidase-zzxf for HER2-positive breast cancer
Engineered immune cells recognise, attack human and mouse solid-tumour cancer cells
Engineered immune cells recognise, attack human and mouse solid-tumour cancer cells

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation